You Own Tempus AI Without Knowing It? Check These ETFs After Its Earnings Surge

Tempus AI jumped after reporting third-quarter results, trading at $80.31 and up 11.21% following results released before the market open. The stock also swung higher earlier, reaching an intraday high of $83.42, before settling to $79.24 at 1:55 PM ET. Revenue rose to $411.54 million, up 23.1% year over year and slightly ahead of $409.30 million consensus. Adjusted EPS was $0.07 versus an expected loss of $0.08, marking Tempus’s sixth straight quarter of beating estimates. On a GAAP basis, the company still posted a loss of $0.08 per share. Adjusted EBITDA increased to $25.57 million from $1.48 million. Management raised full-year revenue guidance to $1.60–$1.605 billion and reiterated adjusted EBITDA around $65 million. The article also notes Tempus’s presence in ARK Innovation ETF (ARKK) and ARK Genomic Revolution ETF (ARKG), while some broader AI and biotech ETFs showed little or no exposure, with investors urged to check current holdings.